Analyst Ratings for Avalo Therapeutics Inc. (AVTX)
AVTX Rating Summary
AVTX Price Target Summary
- Highest: $60.00 (Piper Sandler)
- Lowest: $29.00 (Wedbush)
- Average: $42.13
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$42.13 (+507.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Avg. $ Target:
$42.13 (+507.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/23/2026 | H.C. Wainwright | Mitchel Kapoor | Downgrade | Neutral (Buy) |
N/A (N/A) |
7.45 (6.93) |
-6.98% | Details |
| 10/23/2026 | Guggenheim | Yatin Suneja | Downgrade | Neutral (Buy) |
N/A (N/A) |
7.45 (6.93) |
-6.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
